These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8297720

  • 1. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
    Los G, van Vugt MJ, Pinedo HM.
    Br J Cancer; 1994 Feb; 69(2):235-41. PubMed ID: 8297720
    [Abstract] [Full Text] [Related]

  • 2. Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.
    Los G, Tuyt L, van Vugt M, Schornagel J, Pinedo HM.
    Cancer Chemother Pharmacol; 1993 Feb; 32(6):425-33. PubMed ID: 8258189
    [Abstract] [Full Text] [Related]

  • 3. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
    Los G, Smals OA, van Vugt MJ, van der Vlist M, den Engelse L, McVie JG, Pinedo HM.
    Cancer Res; 1992 Mar 01; 52(5):1252-8. PubMed ID: 1737387
    [Abstract] [Full Text] [Related]

  • 4. Effect of hyperthermia on cisplatin and carboplatin disposition in the isolated, perfused tumour and skin flap.
    Vaden SL, Page RL, Williams PL, Riviere JE.
    Int J Hyperthermia; 1994 Mar 01; 10(4):563-72. PubMed ID: 7963811
    [Abstract] [Full Text] [Related]

  • 5. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Los G, van Vugt MJ, den Engelse L, Pinedo HM.
    Biochem Pharmacol; 1993 Oct 05; 46(7):1229-37. PubMed ID: 8216374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
    Takahashi I, Maehara Y, Kusumoto H, Kusumoto T, Baba H, Kohnoe S, Sugimachi K.
    Oncology; 1996 Oct 05; 53(1):68-72. PubMed ID: 8570136
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS.
    Cancer Res; 1994 Oct 15; 54(20):5380-6. PubMed ID: 7923169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec 15; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer.
    Steller MA, Egorin MJ, Trimble EL, Bartlett DL, Zuhowski EG, Alexander HR, Dedrick RL.
    Cancer Chemother Pharmacol; 1999 Dec 15; 43(2):106-14. PubMed ID: 9923815
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R.
    Klin Padiatr; 2002 Dec 15; 214(4):223-9. PubMed ID: 12165906
    [Abstract] [Full Text] [Related]

  • 20. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 15; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.